Activated protein C-protein C inhibitor complex, activation peptide of carboxypeptidase B and C-reactive protein as predictors of severe acute pancreatitis

Pancreatology

Volumn 9, Issue 5, 2009, Pages 700-707

  Hjalmarsson, Claes ^a,b   Stenflo, Johan ^a   Borgström, Anders ^a  

^a LUND UNIVERSITY   (Sweden)

^b HALMSTAD HOSPITAL   (Sweden)

Author keywords

Activated protein C protein C inhibitor complex; Acute pancreatitis; C reactive protein; Carboxypeptidase B activation peptide

Indexed keywords

ACTIVATED PROTEIN C; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CARBOXYPEPTIDASE B ACTIVATION PEPTIDE; ENZYME ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR 3; TRYPSINOGEN ACTIVATION PEPTIDE; UNCLASSIFIED DRUG;

ACUTE PANCREATITIS; ADULT; AGED; ARTICLE; BLOOD SAMPLING; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; SENSITIVITY AND SPECIFICITY;

EID: 68549125387     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1159/000215577     Document Type: Article

References (30)

1. Svensson JO, Norback B, Bokey EL, Edlund Y: Changing pattern in aetiology of pancreatitis in an urban Swedish area. Br J Surg 1979; 66: 159-161.
2. Giggs J, Bourke J, Katschinski B: The epidemiology of primary acute pancreatitis in Greater Nottingham: 1969-1983. Soc Sci Med 1988; 26: 79-89.
3. Jaakola M, Nordback I: Pancreatitis in Finland between 1970 and 1989. Gut 1993; 34: 1255-1260.
4. Assmus C, Petersen M, Gottesleben F, Drüke M, Lankish P: Epidemiology of acute pancreatitis in a defined German population. Digestion 1996; 57:A217.
5. Pandol SJ, Raraty M: Pathobiology of alcohol pancreatitis. Pancreatology 2007; 7: 105-114.
6. Kemppainen E, Puolakkainen P: Non-alcoholic etiologies of acute pancreatitis - exclusion of other etiologic factors besides alcohol and gallstones. Pancreatology 2007; 7: 142-146.
7. Ranson JH, Pasternack BS: Statistical methods for quantifying the severity of clinical acute pancreatitis. J Surg Res 1977; 22: 79-91.
8. Knaus WA, Draper EA, Wagner DP, Zimmerman JE: APACHE II: a severity of disease classification system. Crit Care Med 1985; 13: 818-829.
9. Andrén Sandberg A, Borgström A: Early prediction of severity in acute pancreatitis. Is this possible? JOP 2002; 3: 116-125.
10. Winslet M, Hall C, London NJ, Neoptolemos JP: Relation of diagnostic serum amylase levels to aetiology and severity of acute pancreatitis. Gut 1992; 33: 982-986.
11. Heath DI, Cruickshank A, Gudgeon M, Je-hanli A, Shenkin A, Imrie CW: Role of inter-leukin-6 in mediating the acute phase pro-tein response and potential as an early means of severity assessment in acute pancreatitis. Gut 1993;34: 41-45.
12. Rau B, Schilling MK, Beger HG: Laboratory markers of severe acute pancreatitis. Dig Dis 2004; 22: 247-257.
13. Appelros S, Petersson U, Toh S, Johnson C, Borgström A: Activation peptide of carboxypeptidase B and anionic trypsinogen as early predictors of the severity of acute pancreatitis. Br J Surg 2001; 88: 216-221.
14. Sáez J, Martinez J, Trigo C, Sánchez-Paya J, Griñó P, Compañy L, Laveda R, Penalva J, Garcia C, Pérez-Mateo M: A comparative study of the activation peptide of carboxypeptidase B and trypsinogen as early predictors of the severity of acute pancreatitis. Pancreas 2004; 29:e9-e14.
15. Sáez J, Martinez J, Trigo C, Sánchez-Paya J, Compañy L, Laveda R, Griñó P, Garcia C, Pérez-Mateo M: Clinical value of rapid urine trypsinogen-2 test strip, urinary trypsinogen activation peptide, and serum and urinary activation peptide of carboxypeptidase B in acute pancreatitis. World J Gastroenterol 2005; 11: 7261-7265.
16. Lindstrom O, Kylanpaa L, Mentula P, Puolakkainen P, Kemppainen E, Haapiainen R, Fernandez J, Griffin J, Repo H, Petaja J: Upregulated but insufficient generation of activated protein C is associated with development of multiorgan failure in severe acute pancreatitis. Crit Care 2006; 10: R16.
17. Ottesen L, Bladbjerg E, Osman, Lausten S, Jacobsen N, Gram J, Jensen S: Protein C activation during the initial phase of experimental acute pancreatitis in the rabbit. Dig Surg 1999; 16: 486-495.
18. Suzuki K, Deyashiki Y, Nishioka J, Toma K: Protein C inhibitor: structure and function. Thromb Haemost 1989; 61: 337-342.
19. Heeb MJ, Griffin JH: Physiological inhibition of human activated protein C by alpha- 1-antitrypsin. J Biol Chem 1988; 263: 11613-11616.
20. Bhiladvala P, Strandberg K, Stenflo J, Holm J: Early identification of acute myocardial infarction by activated protein C - protein C inhibitor complex. Thromb Res 2006; 118: 213-219.
21. Strandberg K, Astermark J, Bjorgell O, Becker C, Nilsson PE, Stenflo J: Complexes between activated protein C and protein C inhibitor measured with a new method: comparison of performance with other markers of hypercoagulability in the diagnosis of deep vein thrombosis. Thromb Haemost 2001; 86: 1400-1408.
22. Nilsson G, Strandberg K, Astermark J, Vernersson E, Stenflo J, Berntorp E: The APCPCI complex concentration predicts outcome of aortic surgery. Thromb Res 2007; 120: 237-244.
23. Bradley EL 3rd: A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, Ga, September 11 through 13, 1992. Arch Surg 1993; 128: 586-590.
24. Muller CA, Appelros S, Uhl W, Büchler MW, Borgström A: Serum levels of procarboxypeptidase B and its activation peptide in patients with acute pancreatitis and non-pancreatic diseases. Gut 2002; 51: 229-235.
25. Strandberg K, Kjellberg M, Knebel R, Lilja H, Stenflo J: A sensitive immunochemical assay for measuring the concentration of the activated protein C-protein C inhibitor complex in plasma: use of a catcher antibody specific for the complexed/cleaved form of the inhibitor. Thromb Haemost 2001; 86: 604-610.
26. Department of Clinical Chemistry MUH: www.labmedicin.org/KlinKem/klinkem. asp. 2007.
27. Pinsky PF: Scaling of true and apparent ROC AUC with number of observations and number of variables. Communications in Statatistics Simulation and Computation 2005; 34: 771-781.
28. Papachristou GI, Whitcomb DC: Predictors of severity and necrosis in acute pancreatitis. Gastroenterol Clin North Am 2004; 33: 871-890.
29. Johnson CD, Lempinen M, Imrie CW, Puolakkainen P, Kemppainen E, Carter R, Mc- Kay C: Urinary trypsinogen activation peptide as a marker of severe acute pancreatitis. Br J Surg 2004; 91: 1027-1033.
30. Neoptolemos JP, Kemppainen EA, Mayer JM, Fitzpatrick JM, Raraty MG, Slavin J, Beger HG, Hietaranta AJ, Puolakkainen PA: Early prediction of severity in acute pancreatitis by urinary trypsinogen activation peptide: a multicentre study. Lancet 2000; 355: 1955-1960.